Literature DB >> 24192122

Genetic variations of human CYP2D6 in the Chinese Han population.

Jian-Chang Qian1, Xin-Min Xu, Guo-Xin Hu, Da-Peng Dai, Ren-Ai Xu, Li-Ming Hu, Fang-Hong Li, Xiu-Hua Zhang, Jie-Fu Yang, Jian-Ping Cai.   

Abstract

AIM: The purpose of this study was to determine the genetic polymorphisms of the CYP2D6 gene and to elucidate the allele distribution pattern in the Chinese Han population. MATERIALS &
METHODS: We used PCR and bidirectional sequencing methods to analyze all nine exons of the CYP2D6 gene in 2129 unrelated, healthy Chinese Han subjects from two geographical locations in China: the northern and southern regions.
RESULTS: In total, 165 mutated sites were detected in 2129 participants, of which 67 sites were reported for the first time. Among these novel mutation sites, 22 were nonsynonymous and 12 were named as novel alleles (*87-*93, *94A, *94B and *95-*98) by the Human CYP Allele Nomenclature Committee. In addition, 29 previously reported alleles and 84 genotypes were also detected in 1954 volunteers. Functional prediction of novel variants revealed that eight variants might have a deleterious effect on CYP2D6. Linkage disequilibrium analysis and tagSNP selection were performed separately. By using these methods, distinct differences were found between the two regions.
CONCLUSION: This study provides the most comprehensive data concerning CYP2D6 polymorphisms in the Chinese Han population to date and increases the number of known alleles; these findings may greatly contribute to the development of personalized medicine for the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24192122     DOI: 10.2217/pgs.13.160

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  20 in total

1.  Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects.

Authors:  Qi Pei; Jinfu Peng; Hongyi Tan; Liu Yang; Xiding Yang; Li Liu; Shikun Liu; Hong Yuan; Guoping Yang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-08-27       Impact factor: 2.441

2.  Pharmacokinetics of dimemorfan phosphate tablets in healthy Chinese volunteers.

Authors:  Yali Shen; Zhu Luo; Qin Yu; Ying Wang; Jin Xiang; Jia Miao
Journal:  Eur J Clin Pharmacol       Date:  2017-02-28       Impact factor: 2.953

3.  Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems.

Authors:  Rui Chen; Haotian Wang; Jun Shi; Kai Shen; Pei Hu
Journal:  Eur J Clin Pharmacol       Date:  2015-05-13       Impact factor: 2.953

4.  Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.

Authors:  Furong Qiu; Songcan Liu; Ping Miao; Jin Zeng; Leilei Zhu; TongFang Zhao; Yujie Ye; Jian Jiang
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

5.  Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.

Authors:  Bingqing Liang; Yunyun Zhan; Xiangxin Huang; Ermin Gu; Dapeng Dai; Jianping Cai; Guoxin Hu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

6.  Novel +90G>A Intronic Polymorphism of CYP2D6.

Authors:  Monir Modaresi-Nejad; Marzieh Shiva; Parvaneh Afsharian
Journal:  Cell J       Date:  2015-04-08       Impact factor: 2.479

7.  Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

Authors:  H Fang; X Liu; J Ramírez; N Choudhury; M Kubo; H K Im; A Konkashbaev; N J Cox; M J Ratain; Y Nakamura; P H O'Donnell
Journal:  Pharmacogenomics J       Date:  2014-07-01       Impact factor: 3.550

8.  Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.

Authors:  Zhe Wang; Li Wang; Ren-Ai Xu; Yun-Yun Zhan; Cheng-Ke Huang; Da-Peng Dai; Jian-Ping Cai; Guo-Xin Hu
Journal:  Drug Des Devel Ther       Date:  2016-06-08       Impact factor: 4.162

9.  National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China.

Authors:  Guigao Lin; Kuo Zhang; Lang Yi; Yanxi Han; Jiehong Xie; Jinming Li
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

10.  Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.

Authors:  Ren-ai Xu; Er-min Gu; Quan Zhou; Lingjing Yuan; Xiaoxia Hu; Jianping Cai; Guoxin Hu
Journal:  Drug Des Devel Ther       Date:  2016-02-15       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.